Trial
NCT03081117
Intranasal Insulin for the Treatment of HAND
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
HIV Dementia
Intervention
Insulin, intranasal
Why stopped
On 3/15/2020 study visits were suspended due to COVID-19 pandemic. With safety concerns surrounding COVID-19 and difficulty recruiting, the investigators decided to close enrollment 10/16/2020 after interim data were reviewed by the DSMB and NIH.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-07